Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 27.33x is 27% above its estimated 2-year average of 21.46x, near the low end of its estimated 2-year range (0.73x–244.40x).
As of 2026-10-06T17:12:45.849Z. 44.99% above its estimated 12-month average of 18.85x.
Calculation as of: 2026-10-06T17:12:45.849Z.
Quote observation: 2026-10-06T17:10:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1c66db039e427230ae26789b54a30ba38da86a4a62527efc47f68a44edb52430
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
27.33x
EV/SALES RATIO AVG TTM
18.85x
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+44.99%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.17x
median of 510 covered companies
CURRENT VS SECTOR MEDIAN
+555.40%
vs the sector median at left
Monte Rosa Therapeutics, Inc.
Market Cap
$837.26M
EV/Sales Ratio
27.33x
TTM Avg
18.85x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$840.18M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$835.64M
EV/Sales Ratio
109.27x
TTM Avg
171.82x
3Y Avg
125.82x
5Y Avg
125.82x
Market Cap
$833.66M
EV/Sales Ratio
6.69x
TTM Avg
7.73x
3Y Avg
8.84x
5Y Avg
8.84x
Market Cap
$830.86M
EV/Sales Ratio
9.27x
TTM Avg
7.35x
3Y Avg
8.21x
5Y Avg
14.47x
Market Cap
$857.24M
EV/Sales Ratio
1.42x
TTM Avg
1.51x
3Y Avg
1.76x
5Y Avg
1.99x
Market Cap
$863.49M
EV/Sales Ratio
3.04x
TTM Avg
2.50x
3Y Avg
2.16x
5Y Avg
2.36x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | $837.26M | 27.33x | 18.85x | N/A | N/A |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $840.18M | N/A | N/A | N/A | N/A |
| Alumis Inc. (ALMS)vs › | $835.64M | 109.27x | 171.82x | 125.82x | 125.82x |
| Beta Bionics, Inc. (BBNX)vs › | $833.66M | 6.69x | 7.73x | 8.84x | 8.84x |
| Pacific Biosciences of California, Inc. (PACB)vs › | $830.86M | 9.27x | 7.35x | 8.21x | 14.47x |
| QuidelOrtho Corporation (QDEL)vs › | $857.24M | 1.42x | 1.51x | 1.76x | 1.99x |
| SL Science Holding Ltd (SLBT)vs › | $858.07M | N/A | N/A | N/A | N/A |
| SI-BONE, Inc. (SIBN)vs › | $860.99M | 3.91x | 3.51x | 4.09x | 5.12x |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $863.49M | 3.04x | 2.50x | 2.16x | 2.36x |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $866.97M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 28.65x |
| 2026-10-02 | 29.34x |
| 2026-10-01 | 31.59x |
| 2026-09-30 | 33.58x |
| 2026-09-29 | 33.02x |
| 2026-09-28 | 32.93x |
| 2026-09-25 | 33.10x |
| 2026-09-24 | 32.96x |
| 2026-09-23 | 33.46x |
| 2026-09-22 | 35.57x |
| 2026-09-21 | 34.56x |
| 2026-09-18 | 34.17x |
| 2026-09-17 | 35.57x |
| 2026-09-16 | 35.72x |
| 2026-09-15 | 36.72x |
| 2026-09-14 | 39.42x |
| 2026-09-11 | 39.93x |
| 2026-09-10 | 40.67x |
| 2026-09-09 | 40.49x |
| 2026-09-08 | 40.52x |
| 2026-09-04 | 39.25x |
| 2026-09-03 | 40.85x |
| 2026-09-02 | 40.37x |
| 2026-09-01 | 40.64x |
| 2026-08-31 | 39.54x |
| 2026-08-28 | 37.88x |
| 2026-08-27 | 40.67x |
| 2026-08-26 | 40.85x |
| 2026-08-25 | 41.38x |
| 2026-08-24 | 39.07x |
| 2026-08-21 | 40.61x |
| 2026-08-20 | 42.03x |
| 2026-08-19 | 44.97x |
| 2026-08-18 | 42.78x |
| 2026-08-17 | 43.81x |
| 2026-08-14 | 44.17x |
| 2026-08-13 | 45.18x |
| 2026-08-12 | 45.51x |
| 2026-08-11 | 44.94x |
| 2026-08-10 | 45.12x |
| 2026-08-07 | 45.30x |
| 2026-08-06 | 28.03x |
| 2026-08-05 | 27.83x |
| 2026-08-04 | 28.75x |
| 2026-08-03 | 27.38x |
| 2026-07-31 | 29.62x |
| 2026-07-30 | 41.71x |
| 2026-07-29 | 39.51x |
| 2026-07-28 | 40.45x |
| 2026-07-27 | 41.48x |
| 2026-07-24 | 41.91x |
| 2026-07-23 | 42.40x |
| 2026-07-22 | 43.89x |
| 2026-07-21 | 43.58x |
| 2026-07-20 | 43.28x |
| 2026-07-17 | 45.40x |
| 2026-07-16 | 42.65x |
| 2026-07-15 | 43.14x |
| 2026-07-14 | 43.24x |
| 2026-07-13 | 40.34x |
| 2026-07-10 | 42.42x |
| 2026-07-09 | 45.32x |
| 2026-07-08 | 44.42x |
| 2026-07-07 | 45.09x |
| 2026-07-06 | 42.83x |
| 2026-07-02 | 44.71x |
| 2026-07-01 | 44.34x |
| 2026-06-30 | 44.70x |
| 2026-06-29 | 44.11x |
| 2026-06-26 | 40.95x |
| 2026-06-25 | 39.71x |
| 2026-06-24 | 38.12x |
| 2026-06-23 | 37.84x |
| 2026-06-22 | 33.84x |
| 2026-06-18 | 33.13x |
| 2026-06-17 | 33.33x |
| 2026-06-16 | 32.05x |
| 2026-06-15 | 32.76x |
| 2026-06-12 | 32.99x |
| 2026-06-11 | 30.76x |
| 2026-06-10 | 29.62x |
| 2026-06-09 | 29.80x |
| 2026-06-08 | 30.56x |
| 2026-06-05 | 29.32x |
| 2026-06-04 | 31.27x |
| 2026-06-03 | 31.72x |
| 2026-06-02 | 32.01x |
| 2026-06-01 | 35.80x |
| 2026-05-29 | 35.88x |
| 2026-05-28 | 35.25x |
| 2026-05-27 | 34.82x |
| 2026-05-26 | 34.88x |
| 2026-05-22 | 34.11x |
| 2026-05-21 | 34.25x |
| 2026-05-20 | 33.80x |
| 2026-05-19 | 31.70x |
| 2026-05-18 | 32.54x |
| 2026-05-15 | 32.82x |
| 2026-05-14 | 33.86x |
| 2026-05-13 | 34.41x |
| 2026-05-12 | 34.70x |
| 2026-05-11 | 36.96x |
| 2026-05-08 | 35.25x |
| 2026-05-07 | 9.77x |
| 2026-05-06 | 10.07x |
| 2026-05-05 | 9.52x |
| 2026-05-04 | 9.64x |
| 2026-05-01 | 9.23x |
| 2026-04-30 | 9.42x |
| 2026-04-29 | 9.19x |
| 2026-04-28 | 9.34x |
| 2026-04-27 | 9.49x |
| 2026-04-24 | 9.75x |
| 2026-04-23 | 9.96x |
| 2026-04-22 | 10.39x |
| 2026-04-21 | 10.34x |
| 2026-04-20 | 9.77x |
| 2026-04-17 | 9.75x |
| 2026-04-16 | 9.18x |
| 2026-04-15 | 8.93x |
| 2026-04-14 | 8.54x |
| 2026-04-13 | 8.57x |
| 2026-04-10 | 8.53x |
| 2026-04-09 | 8.83x |
| 2026-04-08 | 8.34x |
| 2026-04-07 | 8.34x |
| 2026-04-06 | 8.24x |
| 2026-04-02 | 8.32x |
| 2026-04-01 | 8.37x |
| 2026-03-31 | 7.98x |
| 2026-03-30 | 7.50x |
| 2026-03-27 | 7.42x |
| 2026-03-26 | 7.57x |
| 2026-03-25 | 7.59x |
| 2026-03-24 | 7.07x |
| 2026-03-23 | 7.23x |
| 2026-03-20 | 7.55x |
| 2026-03-19 | 7.78x |
| 2026-03-18 | 7.62x |
| 2026-03-17 | 4.53x |
| 2026-03-16 | 4.64x |
| 2026-03-13 | 4.53x |
| 2026-03-12 | 4.53x |
| 2026-03-11 | 4.88x |
| 2026-03-10 | 4.96x |
| 2026-03-09 | 5.08x |
| 2026-03-06 | 5.13x |
| 2026-03-05 | 5.18x |
| 2026-03-04 | 5.41x |
| 2026-03-03 | 5.19x |
| 2026-03-02 | 5.37x |
| 2026-02-27 | 5.12x |
| 2026-02-26 | 5.37x |
| 2026-02-25 | 5.23x |
| 2026-02-24 | 5.61x |
| 2026-02-23 | 5.71x |
| 2026-02-20 | 5.53x |
| 2026-02-19 | 5.60x |
| 2026-02-18 | 5.30x |
| 2026-02-17 | 5.32x |
| 2026-02-13 | 5.17x |
| 2026-02-12 | 5.37x |
| 2026-02-11 | 5.53x |
| 2026-02-10 | 5.73x |
| 2026-02-09 | 5.74x |
| 2026-02-06 | 5.73x |
| 2026-02-05 | 5.51x |
| 2026-02-04 | 5.72x |
| 2026-02-03 | 6.20x |
| 2026-02-02 | 6.18x |
| 2026-01-30 | 6.06x |
| 2026-01-29 | 6.34x |
| 2026-01-28 | 6.27x |
| 2026-01-27 | 6.94x |
| 2026-01-26 | 6.69x |
| 2026-01-23 | 6.85x |
| 2026-01-22 | 6.91x |
| 2026-01-21 | 7.32x |
| 2026-01-20 | 7.39x |
| 2026-01-16 | 7.14x |
| 2026-01-15 | 7.27x |
| 2026-01-14 | 7.26x |
| 2026-01-13 | 7.24x |
| 2026-01-12 | 7.15x |
| 2026-01-09 | 7.34x |
| 2026-01-08 | 7.69x |
| 2026-01-07 | 7.00x |
| 2026-01-06 | 4.52x |
| 2026-01-05 | 3.97x |
| 2026-01-02 | 4.28x |
| 2025-12-31 | 4.41x |
| 2025-12-30 | 4.51x |
| 2025-12-29 | 4.56x |
| 2025-12-26 | 4.96x |
| 2025-12-24 | 5.08x |
| 2025-12-23 | 4.68x |
| 2025-12-22 | 4.58x |
| 2025-12-19 | 4.36x |
| 2025-12-18 | 4.46x |
| 2025-12-17 | 4.77x |
| 2025-12-16 | 5.42x |
| 2025-12-15 | 4.67x |
| 2025-12-12 | 4.63x |
| 2025-12-11 | 4.71x |
| 2025-12-10 | 4.94x |
| 2025-12-09 | 4.86x |
| 2025-12-08 | 5.15x |
| 2025-12-05 | 5.00x |
| 2025-12-04 | 4.95x |
| 2025-12-03 | 4.81x |
| 2025-12-02 | 4.32x |
| 2025-12-01 | 4.44x |
| 2025-11-28 | 4.58x |
| 2025-11-26 | 4.52x |
| 2025-11-25 | 4.53x |
| 2025-11-24 | 4.44x |
| 2025-11-21 | 3.91x |
| 2025-11-20 | 3.68x |
| 2025-11-19 | 3.89x |
| 2025-11-18 | 3.76x |
| 2025-11-17 | 3.71x |
| 2025-11-14 | 3.96x |
| 2025-11-13 | 3.95x |
| 2025-11-12 | 3.89x |
| 2025-11-11 | 3.95x |
| 2025-11-10 | 3.86x |
| 2025-11-07 | 3.26x |
| 2025-11-06 | 4.35x |
| 2025-11-05 | 4.11x |
| 2025-11-04 | 4.00x |
| 2025-11-03 | 4.03x |
| 2025-10-31 | 4.30x |
| 2025-10-30 | 4.35x |
| 2025-10-29 | 4.18x |
| 2025-10-28 | 4.15x |
| 2025-10-27 | 4.11x |
| 2025-10-24 | 3.70x |
| 2025-10-23 | 3.44x |
| 2025-10-22 | 3.08x |
| 2025-10-21 | 3.17x |
| 2025-10-20 | 3.26x |
| 2025-10-17 | 3.33x |
| 2025-10-16 | 3.42x |
| 2025-10-15 | 3.69x |
| 2025-10-14 | 3.52x |
| 2025-10-13 | 3.45x |
| 2025-10-10 | 3.32x |
| 2025-10-09 | 2.77x |
| 2025-10-08 | 2.51x |
| 2025-10-07 | 2.40x |
| 2025-10-06 | 2.50x |
| 2025-10-03 | 2.52x |
| 2025-10-02 | 2.49x |
| 2025-10-01 | 2.44x |
| 2025-09-30 | 2.41x |
| 2025-09-29 | 2.38x |
| 2025-09-26 | 2.44x |
| 2025-09-25 | 2.11x |
| 2025-09-24 | 2.14x |
| 2025-09-23 | 2.04x |
Showing the most recent 260 of 602 data points. The chart above shows the full history.
